已发表论文

蛋白酶体(Proteasome),有望成为癌症以外多种疾病的治疗目标

 

Authors Cao Y, Zhu H, He R, Kong L, Shao J, Zhuang R, Xi J, Zhang J

Received 16 June 2020

Accepted for publication 22 September 2020

Published 19 October 2020 Volume 2020:14 Pages 4327—4342

DOI https://doi.org/10.2147/DDDT.S265793

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 2

Editor who approved publication: Professor Jianbo Sun

Abstract : Proteasome is vital for intracellular protein homeostasis as it eliminates misfolded and damaged protein. Inhibition of proteasome has been validated as a powerful strategy for anti-cancer therapy, and several drugs have been approved for treatment of multiple myeloma. Recent studies indicate that proteasome has potent therapeutic effects on a variety of diseases besides cancer, including parasite infectious diseases, bacterial/fungal infections diseases, neurodegenerative diseases and autoimmune diseases. In this review, recent developments of proteasome inhibitors for various diseases and related structure activity relationships are going to be summarized.
Keywords: proteasome inhibitor, infectious diseases, autoimmune diseases, neurodegenerative diseases, drugs